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Abstract
In recent years, multiple pregnancy rates have increased significantly. Twin 
pregnancy rate increased by 76% between 1980 and 2009, from 18.9 to 33.3 in 1000 
births. Triplets and high-order multiple pregnancies have increased by 400% in 
the 1980s and 1990s. Two main reasons of this increase in the incidence of multiple 
pregnancies are: (1) maternal age at the time of conception, shifting to advanced 
ages where multiple pregnancies are more common and (2) a more common use 
of assisted reproductive techniques. The main problem in multiple pregnancies is 
spontaneous preterm delivery and associated neonatal morbidity and mortality. 
Although numerous attempts have been made to prolong the gestation period and 
improve outcomes, none of them have been effective. In this article, the complica-
tions encountered in multiple pregnancies will be summarized and evidence-based 
approaches that can be used in their management will be reported.
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1. Introduction
Multiple pregnancy rates have increased significantly in recent years. The twin 
pregnancy rate increased from 18.9 to 33.3 per 1,000 births between 1980 and 
2009, increasing by 76% [1]. Multiple pregnancies with triplets and higher numbers 
increased by 400% in the 1980s and 1990s [2]. There are two main reasons for this 
increase in the incidence of multiple pregnancies: (1) Maternal age at the time of 
conception is shifting to advanced ages with multiple pregnancies and (2) a more 
common use of assisted reproductive techniques [3].
The main problem encountered in multiple pregnancies is spontaneous preterm 
labor and associated neonatal morbidity and mortality. Although several attempts 
have been made to prolong the duration of these pregnancies and improve out-
comes, none of them have been effective. In this chapter, the complications encoun-
tered in multiple pregnancies will be summarized and evidence-based approaches 
that can be applied in their management will be reported.
2. Fetal and neonatal morbidity and mortality
Due to complications caused by preterm labor, stillbirth rate in multiple preg-
nancies is five times higher, and neonatal mortality rate is seven times higher than 
other pregnancies. A woman with a multiple pregnancy is 6 times more likely to 
have a preterm delivery and 13 times more likely to give birth before 32 weeks of 
gestation [4].
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In multiple pregnancies, short- and long-term morbidity has also increased. 
Severe intraventricular hemorrhage and periventricular leukomalacia are two times 
more common in twins born before 32 weeks of gestation than in single babies 
born in the same week [5], and this explains the increased rate of cerebral palsy in 
multiple pregnancies [6].
In multiple pregnancies, still due to the prematurity, health expenses in 
both antenatal and neonatal periods are higher [7]. The spending made for 
preterm babies in the year after birth reaches 10 times the spending for full-term 
babies [8].
3. Chorionicity
Ultrasound is the reliable method to detect multiple pregnancies [9]. Ultrasound 
shows the number of fetuses, gestational week, chorionicity, and amnionicity. It is 
very important to detect chorionicity which is best assessed by ultrasound in the 
first or early second trimester.
Fetal and neonatal mortality and morbidities such as congenital anomaly, 
prematurity, and intrauterine growth restriction are much more common in mono-
chorionic twins than in dichorionic twins [10, 11]. This also applies to high number 
of multiple pregnancies; completely monochorionic or monochorionic twin pairs 
have a higher risk of developing complications compared to trichoricionic triplet 
pregnancy [12, 13]. Thus, chorionicity should be determined in the late stages of the 
first trimester or early second trimester for the management of multiple pregnan-
cies and consultancy.
4. Maternal morbidity and mortality
Medical complications such as hyperemesis, gestational diabetes, hypertension, 
anemia, bleeding, cesarean section, and postpartum depression are more common 
in women with multiple pregnancies [14–20]. These complications are managed as 
in singleton pregnancies.
The incidence of hypertensive complications is proportional to the number of 
fetuses, with 6.5% in singleton pregnancies, 12.7% in twins, and 20% in triplets [21].
In one study, it was found that the risk of developing mild or severe preeclamp-
sia in pregnancies achieved by assisted reproductive techniques was 2.1 times higher 
than other pregnancies with the same maternal age and parity [22].
Preeclampsia occurs both more frequently (relative risk 2.6) and earlier in twin 
pregnancies. This results in a higher probability of developing complications such as 
birth before 35 weeks of gestation (34.5% in twins vs. 6.3% in singles) and ablation 
of the placenta (4.7% in twins vs. 0.7% in singles) [16]. While preeclampsia is more 
common in patients with higher-order gestations, it is atypical [23]. If hemolysis, 
elevated liver enzymes, and low platelet count (HELLP syndrome) occur before 
term, the patient’s referral to the third line will be better for both the mother and 
the fetus [24].
The incidence of multiple pregnancy increases with age, regardless of assisted 
reproductive techniques. While the multiple pregnancy rate in women aged under 
20 is 16.3 per 1000 live births, this rate is 71.1 per 1000 live births in women over 40 
[2]. Regardless of the number of fetuses, obstetric complications such as gestational 
hypertension, gestational diabetes, and ablation placenta are more common in 
older women.
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5. Effect of assisted reproductive techniques
In the past years, the proliferation of assisted reproductive techniques has led 
to a serious increase in multiple pregnancy rates [1]. In recent years, there was 
a decrease in higher-order gestation rates with the limitation of the number of 
embryos transferred in vitro fertilization (IVF) and the proliferation of embryo 
reduction. The techniques that cause the most increase in the number of multiple 
pregnancies are IVF and controlled ovarian hyperstimulation with gonadotropins. 
According to the most recent data obtained in 2010, 26% of IVF pregnancies result 
in twins, and 1.3% in higher-order gestations [25].
6. Embryo reduction and selective feticide
Embryo reduction causes a decrease in the risk of spontaneous preterm labor 
and other obstetric complications with decreased fetal number. In a Cochrane 
review, it was reported that the pregnancy loss, antenatal complication, preterm 
birth, low birth weight, and cesarean and neonatal death rates in pregnant women 
undergoing triplet-to-twin reduction were much lower than in those continuing as 
triplets and were close to the rates seen in spontaneous twins [26]. Embryo reduc-
tion in higher-order gestations also reduces the risk of preeclampsia. In one study, 
the preeclampsia incidence was 17% in pregnancies with reduction to twins and 
30% in pregnancies continuing as triplets [27].
In embryo reduction, the decision of which fetus or fetuses will be treated 
is determined according to chorionicity and easy accessibility. When one of 
the monochorionic twin pair is reduced, it is recommended that both mono-
chorionic pair be reduced, since the harmful effects on the other twin are not 
fully known.
Selective feticide is the reduction of abnormal fetus in a multiple pregnancy. The 
risk of this procedure is higher compared to embryo reduction, since it is per-
formed at a later gestational week (18th–22nd week instead of 10–12th week) [28]. 
In higher-order gestations, unwanted loss of healthy fetuses is higher than twins 
(11.2% vs. 2.4%) [29]. It was observed that gestation period was longer in pregnan-
cies without pregnancy loss [30, 31].
7. Questions and suggestions about clinic
7.1 How to determine chorionicity?
Since fetal risks depend on chorionicity, chorionicity should be determined 
as early as possible. The ideal period for the determination of chorionicity is late 
first or early second trimester. In a series, the sensitivity, specificity, and positive 
and negative predictive values of ultrasound in determining chorionicity before 
14 weeks of gestation were 89.8%, 99.5%, 97.8%, and 97.5%, respectively [32], and 
chorionicity was correctly determined in 95% of cases.
The pregnancy is dichorionic if the ultrasound shows two separate placentas or 
the gender of fetuses are different. In the case of a single placenta, the most impor-
tant ultrasound finding used to determine chorionicity is the “twin peak” finding, 
also known as “lambda” or “delta” sign. This finding shows that there is a triangular 
shaped protrusion on the chorionic surface of the placenta having the same echo-
genicity as the placenta and pregnancy is dichorionic [33].
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7.2 Is there a test to predict spontaneous preterm labor in multiple pregnancies?
In order to determine the risk of spontaneous preterm labor in asymptomatic 
pregnant women, many screening methods such as measuring cervical canal length 
with transvaginal ultrasound, examination of the cervix, fetal fibronectin screen-
ing, and home uterus monitoring have been tried. These screening methods are not 
recommended in asymptomatic women because there is no intervention that can 
prevent preterm labor in multiple pregnancies that are found to be at high risk for 
preterm labor [34].
In symptomatic pregnant women, the positive predictive value of fetal fibronec-
tin test alone or short cervical length is low and should not be used for the manage-
ment of acute symptoms [35]. Although observational studies have shown that fetal 
fibronectin or cervical canal length precludes the use of unnecessary treatment in 
singleton pregnancies with preterm labor symptoms, these data have not been proven 
by randomized controlled trials for either singleton or multiple pregnancies [36–40].
7.3 Are there any interventions to extend the duration of multiple pregnancy?
There is no evidence that interventions such as prophylactic cerclage, routine 
hospitalization and bed rest, prophylactic tocolysis, and prophylactic pessary 
reduce neonatal morbidity and mortality. Hence, their use is not recommended in 
multiple pregnancy.
7.3.1 Prophylactic cerclage
The benefit of prophylactic cerclage in a twin or triplet pregnancy without a 
history of cervical insufficiency has not been shown [41–43]. In addition, prophy-
lactic cerclage has been reported to increase spontaneous preterm labor by twofold 
in pregnant women with a short cervical canal on ultrasound (RR, 2.2; 95% [CI], 
1.2–4.0) [44, 45]. Therefore, cerclage should be avoided in multiple pregnancies.
7.3.2 Routine hospitalization and bed rest
In a Cochrane review, hospitalization or bed rest has been shown to have no 
benefit in uncomplicated twin pregnancies [46]. For this reason, routine bed rest 
should not be recommended to women pregnant with multiples due to the lack of 
benefit and the risk of thrombosis.
7.3.3 Prophylactic tocolysis
No tocolytic agent should be used for prophylaxis in multiple pregnancies. Maternal 
complications from tocolysis, such as pulmonary edema, are more common in multiple 
pregnancies [47, 48]. There are also no data that these drugs reduce the risk of pre-
term labor or improve neonatal outcomes [49–51]. Oral betamimetics did not reduce 
preterm delivery, low birth weight, or neonatal mortality in multiple pregnancies 
compared to placebo [52]. Oral betamimetics are also associated with maternal and 
fetal cardiac stress and gestational diabetes [53, 54]. It has recently been demonstrated 
to be associated with adverse maternal cardiovascular events, including death [55].
7.3.4 Prophylactic pessary
There is no scientific evidence that prophylactic cervical pessary reduces 
the frequency of spontaneous preterm labor or perinatal morbidity in multiple 
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pregnancies. In a recent multicenter randomized controlled study, 813 twin preg-
nancies from 16 to 20 weeks were randomized [56], and poor perinatal outcome 
was observed in at least 1 baby of 13% of women treated by Arabin pessary and 14% 
of other women (RR, 0.98 CI 0.69–1.39). Therefore, the use of prophylactic cervical 
pessary is not recommended in multiple pregnancies [56].
7.4  Does progesterone treatment reduce the risk of preterm labor in multiple 
pregnancies?
Progesterone treatment is not recommended in multiple pregnancies since it 
does not decrease the incidence of preterm labor [57–63]. In one study, it was shown 
that the use of 17α-hydroxyprogesterone caproate did not reduce neonatal morbid-
ity and prolong pregnancy in triplet pregnancies [61]. In another randomized study, 
it was shown to significantly increase the rates of fetal loss in the second trimester 
in triplets [60]. In multiple pregnancies that the cervix was found to be short on 
transvaginal ultrasound, neither 17α-hydroxyprogesterone caproate nor vaginal 
progesterone has been demonstrated to be beneficial [64–67].
7.5 How to manage preterm labor in multiple pregnancies?
7.5.1 Tocolytics
Calcium channel blockers or nonsteroidal anti-inflammatory drugs are first-line 
tocolytic agents. Although there are no large-scale randomized studies conducted 
only with multiple pregnancies, the current scientific data were obtained from 
studies involving multiple pregnancies as well as singleton pregnancies [68]. 
Therefore, in case of an acute preterm labor in multiple pregnancies, short-term 
tocolysis can be administered up to 48 hours to allow for the administration of 
corticosteroids.
7.5.2 Corticosteroids
In a Cochrane review, it was concluded that antenatal corticosteroid is beneficial 
in singleton pregnancies and further studies are required for the outcomes in mul-
tiple pregnancies [69]. However, based on its proven benefits in singleton pregnan-
cies, the National Institute of Health recommends the administration of antenatal 
corticosteroids to pregnant women from 24 to 34 weeks of gestation and who are at 
risk of giving birth within 7 days, unless there is a contraindication, regardless of 
the number of fetuses [70, 71].
7.5.3 Magnesium sulfate for fetal neuroprotection
Magnesium sulfate has been shown to reduce the risk and severity of cerebral 
palsy, regardless of the number of fetuses, at birth before 32 weeks [72–78].
7.6 Prenatal screening in multiple pregnancies
In multiple pregnancies, the probability of one or more fetuses being affected 
by trisomy is mathematically higher than in singleton pregnancies. For example, 
maternal age-dependent risk of trisomy in dizygotic twins is twice as much as 
a singleton pregnancy at the same age [79]. Therefore, the risk of a 33-year-old 
woman expecting twins is equal to that of a 35-year-old singleton pregnant 
woman [80].
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Aneuploidy screening has many limitations in multiple pregnancies. Serum 
screening tests in twin or triplet pregnancies are not as sensitive as in singleton 
pregnancies. The detection rate of trisomy 21 by the second trimester maternal 
serum screening test in twin pregnancies has been reported to be 63% (71% when 
both fetuses are affected and 60% when only one is affected) with a false-positive 
rate of 10.8% [81]. In the first trimester screening test, where maternal age, nuchal 
transparency, and biochemical markers are evaluated together in twin pregnan-
cies, the detection rate is 75–85% for Down syndrome and 66.7% for trisomy 18, 
with a false-positive rate of 5% [82–85]. Experience with triplet pregnancies is 
scarce, but studies show that screening for only nuchal transparency and maternal 
age is reliable. However, one study has shown that the nuchal transparency above 
the 95th percentile in monochorionic twin pregnancies predicts 38% of twin-
to-twin transfusion syndrome that will develop later, making the interpretation 
of the first trimester screening results even more complicated in monochorionic 
pregnancies [86].
Noninvasive prenatal testing can be used for fetal aneuploidy screening, but 
further data is required to recommend its use in multiple pregnancies [87].
7.7  What are the problems encountered in the prenatal diagnosis of aneuploidy 
in multiple pregnancies?
Women who wish to have a definitive diagnosis of genetic abnormalities may 
have an amniocentesis and chorionic villus sampling (CVS). The procedure-related 
risk of miscarriage for both tests is similar (1–1.8%) and slightly higher compared 
to singleton pregnancies [88–90]. The main advantage of having CVS is that CVS 
is performed earlier in pregnancy. However, in multiple pregnancies, some techni-
cal difficulties are encountered during these procedures. In approximately 1% of 
multiple pregnancies, sample for CVS was collected from the wrong fetus [91]. This 
risk is lower in amniocentesis. To avoid the risk of sampling error, indigo carmine 
is injected into the first sampled sac after amniocentesis. The absence of dye in the 
fluid from the second sac proves that sampling was done from two different sacs. 
Due to the low probability of karyotype being discordant in monochorionic twins, 
pregnant women may prefer karyotype analysis of a single fetus. Thus, the success 
of ultrasound in determining chorionicity should be explained to pregnant women.
When aneuploidy is diagnosed, if a fetus is affected, the parents are offered 
several options, such as termination of the entire pregnancy, selective reduction of 
the affected fetus, or continuation of pregnancy without any intervention.
7.8  What is the prognosis of multiple pregnancies that are discordant in terms of 
the size of the fetuses?
Discordant growth in multiple pregnancies is generally defined as a difference 
of at least 20% between the estimated fetal weights of two fetuses [92, 93]. This rate 
is calculated by dividing the difference between the weights of the two fetuses by 
the weight of the larger fetus. It is controversial whether growth discordance leads 
to negative outcomes in the absence of structural anomaly, aneuploidy, discordant 
infection, oligohydramnios, or fetal growth restriction. There are studies showing 
that fetal or neonatal morbidity and mortality do not increase in cases where weight 
discordance is present but the weight of both fetuses complies with that gestational 
week [94–97]. However, in multiple pregnancies where the growth of at least one 
fetus is limited, major neonatal morbidity increases by 7.7 times [98]. In addition, 
perinatal mortality and morbidity rates were higher in twins with growth restric-
tion than in singleton pregnancies in the same gestational week [99]. In summary, 
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although there is no evidence that neonatal morbidity and mortality increase in 
twins with discordance only, the risk of adverse perinatal outcomes increases in the 
presence of an abnormal finding such as fetal growth restriction accompanied by 
discordance.
7.9 How to manage the death of a fetus?
In the first trimester, spontaneous reduction occurs in one or more fetuses in 
many of the multiple pregnancies [100]. This likelihood of reduction is propor-
tional to the number of gestational sacs (36% in twins, 53% in triplets, 65% in qua-
druplets [101]). In the second or third trimester, the death of one or more fetuses 
is seen in 5% of twins and 17% of triplets [102]. Chorionicity affects the loss rate 
and helps determine the prognosis and manage the living fetus. In monochorionic-
diamniotic twins, the rate of fetal death is higher than in dichorionic-diamniotic 
twins [103–105]. In fetal deaths after the 14th week of pregnancy, the probability of 
death of the other twin is 15% in monochorionic twins and 3% in dichorionic twins 
[105]. The probability of developing neurological abnormalities in the living fetus is 
18% in monochorionic twins and 1% in dichorionic twins [106, 107]. Despite these 
risks, the immediate delivery of the other twin has no benefit [108]. Therefore, in 
monochorionic twin pregnancies, if one of the fetuses dies before the 34th gesta-
tional week, the pregnancy should be managed according to the mother and the 
living fetus. Unless there is another indication, delivery should not be done before 
34th week [109]. The timing of birth should be determined according to the patient 
and in consultation with those trained in maternal-fetal medicine.
7.10 How to perform antepartum fetal follow-up in dichorionic pregnancies?
After determining chorionicity in the first or early second trimester, the 
anatomy, size, amount of amniotic fluid, and placenta should be evaluated with 
ultrasound at 18–22 weeks of gestation. The growth rate of fetuses in uncomplicated 
twin pregnancies is approximately the same as single pregnancies up to 28–32 weeks 
[110]. Although there is no scientific evidence suggesting that ultrasound should 
be performed to evaluate fetal growth after the 20th week, it seems reasonable to 
monitor dichorionic twin pregnancies without fetal growth restriction or other 
pregnancy complications every 4–6 weeks with serial ultrasound.
It has not been shown that antepartum tests or umbilical artery Doppler ultra-
sound improves perinatal outcomes in uncomplicated twin pregnancies [111]. Tests 
evaluating fetal well-being in dichorionic twins should only be used when there are 
fetal or maternal complications such as fetal growth restriction.
7.11 How to manage complications caused by monochorionic placentation?
Monochorionic pregnancies should be monitored more closely than dichorionic 
twins because of the higher risk of complications [112]. Monitoring of pregnancy 
with serial ultrasound every 2 weeks from the 16th week should be considered 
[113–115].
7.11.1 Twin-to-twin transfusion syndrome
Twin-to-twin transfusion syndrome develops in approximately 10–15% of 
monochorionic-diamniotic pregnancies and is due to arteriovenous anastomoses 
in the monochorionic placenta. It usually occurs in the second trimester and is 
diagnosed by the presence of oligohydramnios (the largest vertical pocket is smaller 
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than 2 cm) in one sac and polyhydramnios (the largest vertical pocket is larger than 
8 cm) in the other sac. A fetal discordance and selective fetal growth restriction due 
to structural and genetic anomalies or infectious diseases should be ruled out. The 
benefits of umbilical artery Doppler have not been demonstrated in cases where 
there is no growth and fluid discordance. The prognosis of twin-to-twin transfusion 
syndrome varies by the week of gestation and the severity of the syndrome. Staging 
is based on the Quintero classification system shown in Table 1, and treatment with 
laser coagulation or amnioreduction therapy is frequently used [112, 116].
7.11.2 Monoamniotic twins
The natural incidence of monoamniotic twin pregnancy is one in 10,000, but 
the incidence may be higher in zona-manipulated IVF pregnancies [117]. Perinatal 
mortality rates associated with cord complications have been reported as high as 
80% [118]. Although the ideal management of these pregnancies is not clearly 
known, daily fetal heart monitoring in hospital conditions from 24 to 28 weeks 
of gestation and delivery at 32–34 weeks of gestation are the common practice 
[118–120].
7.11.3 Rare complications
Acardiac twin pregnancy occurs in 1% of monochorionic pregnancies and is 
characterized with a fetus that does not have a normally developed heart and brain 
[121]. This fetus continues to live by the anastomoses in the placenta and the blood 
supplied by the other fetus (pumping twin). Therefore, the pumping fetus is at risk 
of cardiac insufficiency, and intrauterine or neonatal loss occurs in nearly half of 
the cases [122]. This rare condition should be managed by a maternal-fetal medicine 
specialist experienced in twin pregnancy management.
Conjoined twin is a rare phenomenon, occurring 1 in 50,000–100,000 [123]. 
After the diagnosis, it should be determined which organs are shared for the prog-
nosis [124]. The survival rate of a conjoined twin detected in the intrauterine period 
is only 18% even after successful surgery [125].
7.12 What should be the time and mode of delivery in multiple pregnancies?
The time of spontaneous delivery in twin pregnancies is around 36 weeks, and 
so the complications of prematurity are an important risk [126]. Perinatal mortality 
increases again after 38 weeks of gestation [127]. Accordingly the time of delivery 
for uncomplicated twin pregnancies would be reasonable [108]:
Stage 1.  Monochorionic-diamniotic gestation with oligohydramnios (MVP less than 2 cm) and 
polyhydramnios (MVP greater than 8 cm)
Stage 2. Absent (empty) bladder in donor
Stage 3. Abnormal Doppler ultrasonography findings*
Stage 4. Hydrops
Stage 5. Death of one or both twins
Abbreviation: MVP, maximum vertical pocket. Data from [140].
*Defined as the presence of one or more of the following: umbilical artery absent or reversed diastolic flow; ductus 
venosus absent or reversed diastolic flow; or umbilical vein pulsatile flow.
Table 1. 
Staging of twin-to-twin transfusion syndrome.
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a. At 38 weeks in dichorionic diamniotic twins without complications
b. From 34 to 37 6/7 weeks in monochorionic-diamniotic pregnancies without 
complications
c. From 32 to 34 weeks in monoamniotic pregnancies without complications
The ideal mode of delivery varies by the type of twin pregnancy, the presenta-
tion of the fetuses, the gestational week, and the experience of the delivering 
physician. Twin pregnancy alone is not an indication of cesarean section [128]. In 
monoamniotic pregnancies only, cesarean delivery is required to avoid cord compli-
cations that may develop in the other fetus during the birth of the first fetus [118].
In a recently published randomized controlled study, no difference was reported 
between planned cesarean and planned vaginal delivery in terms of fetal and neo-
natal death or severe neonatal morbidity between 32 and 38 6/7 weeks of gestation 
in twin pregnancies with cephalic presentation of the first fetus [129]. Therefore, in 
diamniotic twin pregnancies with cephalic presentation of the first fetus after the 
32nd gestational week, vaginal delivery appears to be a logical option, regardless of 
the presentation of the second fetus, provided that the obstetrician is experienced 
in internal podalic version and vaginal breech delivery [130].
The ideal delivery method in higher-order multiple pregnancies is not known. 
In small observational studies, there was no significant difference between planned 
vaginal delivery and planned cesarean delivery with the cephalic presentation of the 
first fetus in uncomplicated triplet pregnancies. Therefore, planned vaginal delivery 
may be considered in these pregnancies if obstetrician is experienced [131–133]. 
Vaginal delivery can be attempted in twin pregnancies with a previous history of 
cesarean section with a single lower transverse incision and without any contrain-
dications for vaginal delivery [134–138]. Internal fetal manipulation or emergency 
cesarean section may be required during delivery. Women with multiple pregnan-
cies are at risk for atony, postpartum bleeding, and emergency hysterectomy [139]. 
The administration of neuroaxial analgesia facilitates operative vaginal delivery, 
external or internal cephalic version, and total breech extraction in multiple 
pregnancies [130].
8. Summary of findings and recommendations
A. Recommendations based on reliable scientific data (with evidence level A)
• No tocolytic agent is recommended for prophylactic use in multiple 
pregnancies.
• Treatment with progesterone does not reduce the incidence of spontaneous 
preterm delivery in twin and triplet pregnancies.
B. Recommendations based on limited scientific data (with evidence level B)
• Chorionicity should be determined in the late stages of the first trimes-
ter or in the early stages of the second trimester due to complications of 
monochorionicity.
• Since prophylactic tocolysis, prophylactic cerclage, prophylactic pessary, 
routine hospitalization, and bed rest have not been shown to reduce neonatal 
Multiple Pregnancy
10
morbidity and mortality, these practices are not recommended in multiple 
pregnancies.
• Magnesium sulfate has been shown to reduce the risk and severity of cerebral 
palsy, regardless of the number of fetuses, at birth before 32 weeks.
• In women with a previous history of cesarean section with a transverse inci-
sion to the lower segment, vaginal delivery can be attempted unless there is 
another contraindication.
• In pregnancies in which the number of fetuses is reduced from three to two 
with embryo reduction, pregnancy loss, antenatal complications, preterm 
delivery, low birth weight, and cesarean and neonatal mortality rates are 
lower than in pregnancies continuing as triplets and are similar to spontane-
ous twin pregnancies.
• Unless there are contraindications, a cycle of antenatal corticosteroid should 
be administered to women pregnant with multiples from 24 to 34 weeks of 
gestation and who are expected to give birth within 7 days regardless of the 
number of fetuses.
C. Recommendations based on expert opinion (with evidence level C)
• Delivery in uncomplicated monoamniotic twins should be at 32–34 weeks of 
gestation.
• In diamniotic twin pregnancies over 32 0/7 weeks with cephalic presentation 
of the first fetus, vaginal delivery appears to be a logical option, regardless 
of the presentation of the second fetus, provided that the obstetrician is 
experienced in internal podalic version and vaginal breech delivery.
• Women with multiple pregnancies are candidates for routine aneuploidy 
screening regardless of age.
• Administration of neuroaxial (epidural) analgesia in multiple pregnancies 
facilitates operative vaginal delivery, external or internal cephalic version, 
and total breech extraction.
• Monoamniotic twin pregnancies should be delivered by cesarean.
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